A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells

NCT00703222 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP
BIOLOGICAL: SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2 SKNLP

Sponsor

Baylor College of Medicine

Collaborators

[object Object]